专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08350319B2 Semiconductor device 失效
标题翻译：半导体器件
公开(公告)号：US08350319B2
公开(公告)日：2013-01-08
申请号：US13078436
申请日：2011-04-01
申请人： Shigeto Fujita , Khalid Hassan Hussein , Junichi Yamashita , Hisao Kondo
发明人： Shigeto Fujita , Khalid Hassan Hussein , Junichi Yamashita , Hisao Kondo
IPC分类号： H01L29/66 , H01L21/336
CPC分类号： H01L29/4983 , H01L29/1095 , H01L29/42372 , H01L29/4238 , H01L29/7811
摘要： A semiconductor device includes a gate pad, a gate wiring conductor connected to the gate pad, and a gate electrode formed under the gate pad and the gate wiring conductor. Portions of the gate electrode closer to the gate pad have a higher resistance per unit area than portions of the gate electrode farther away from the gate pad.
摘要翻译：半导体器件包括栅极焊盘，连接到栅极焊盘的栅极布线导体以及形成在栅极焊盘和栅极布线导体下面的栅电极。靠近栅极焊盘的栅电极的部分具有比栅极电极远离栅极焊盘的部分更高的每单位面积的电阻。

2. 发明申请

US20110152555A1 PLATINUM COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 失效
标题翻译：铂复合物和含有它们的药物组合物
公开(公告)号：US20110152555A1
公开(公告)日：2011-06-23
申请号：US13060906
申请日：2009-08-25
申请人： Hisae Arai , Masaji Ohno , Hisao Kondo , Ikuko Arai
发明人： Hisae Arai , Masaji Ohno , Hisao Kondo , Ikuko Arai
IPC分类号： C07F15/00
CPC分类号： C07C55/07 , C07C61/04 , C07C211/38 , C07C2602/50 , C07F15/0093
摘要： A new platinum complex which has strong antitumor activity and has effect with smaller doses and a pharmaceutical composition containing the same are provided. A spiro[4,4]nonane-1,6-diamineplatinum(II) complex which is represented by a following general formula (A). (In the formula, X and Y are same or different, and X and Y represent halogen atoms respectively, or X and Y cooperatively represent a divalent residue which is described by a formula (Z).) The platinum complex has a strong antitumor activity and is efficacious as a therapeutic agent for malignant tumors.
摘要翻译：提供了具有强抗肿瘤活性并具有较小剂量效果的新型铂络合物和含有该铂络合物的药物组合物。由以下通式（A）表示的螺[4,4]壬烷-1,6-二氨基铂（II）络合物。（式中X和Y相同或不同，X和Y分别表示卤素原子，或X和Y表示二价残基，由式（Z）表示）。铂络合物具有强的抗肿瘤活性并且作为恶性肿瘤的治疗剂是有效的。

3. 发明申请

US20080024694A1 LIQUID CRYSTAL DISPLAY DEVICE 有权
标题翻译：液晶显示装置
公开(公告)号：US20080024694A1
公开(公告)日：2008-01-31
申请号：US11459882
申请日：2006-07-25
申请人： Hisao KONDO , Katsumi Tsuchida , Hisashi Narita , Shigenori Oota
发明人： Hisao KONDO , Katsumi Tsuchida , Hisashi Narita , Shigenori Oota
IPC分类号： G02F1/1333
CPC分类号： G02F1/133615 , G02B6/0083 , G02B6/0085 , G02B6/009 , G02F2001/133628
摘要： A liquid crystal display device comprising a liquid crystal display panel, a backlight and a heat sink member is disclosed. The backlight comprises a light-guiding plate disposed on one principal surface side of the liquid crystal display panel, LED light sources disposed on an end surface of the light-guiding plate, a mounting board for mounting the LED light sources thereon and a thermally conductive member connected to the mounting board. The heat sink member is connected to the mounting board through the thermally conductive member.
摘要翻译：公开了一种包括液晶显示面板，背光和散热构件的液晶显示装置。背光源包括设置在液晶显示面板的一个主表面侧的导光板，设置在导光板的端面上的LED光源，用于在其上安装LED光源的安装板和导热板连接到安装板的构件。散热构件通过导热构件连接到安装板。

4. 发明申请

US20060157890A1 Window assembly-producing method and window plate 有权
标题翻译：窗组装生产方法和窗板
公开(公告)号：US20060157890A1
公开(公告)日：2006-07-20
申请号：US10563374
申请日：2004-06-14
申请人： Katsuyuki Amano , Akihiro Suzuki , Tatsuya Tamura , Hisao Kondo
发明人： Katsuyuki Amano , Akihiro Suzuki , Tatsuya Tamura , Hisao Kondo
IPC分类号： B29C45/14
CPC分类号： B29C45/14377 , B29C45/14311 , B29C45/14434 , B29C45/14778 , B29C2045/0093 , B29K2709/08 , B29L2031/7782 , B60J1/004
摘要： An adhesive agent is uniformly applied to a back surface of a window pane, the application made to an area where a covering member is planned to be adhered and to an area where a positioning fixture and a holding portion are planned to be adhered, the application is also made continuously such that adhesive agent layers of both planned adhesion areas being continuous with an adhesive agent continuous area in between. After that, the window pane and the positioning fixture are set in an injection mold and a polymer material is injected in the mold. This results that the covering member and the holding portion are formed into a shape where they are connected by a connection portion for material flow, which connection portion is formed at a position other than the adhesive agent continuous area. The forming results that the covering member and the holding portion are adhered and fixed to the back surface of the window pane with the adhesive agent layers in between. After the forming process above, the connection portion for material flow is removed.
摘要翻译：将粘合剂均匀地施加到窗玻璃的后表面上，将涂布物制成覆盖部件被计划粘附的区域和计划粘贴定位夹具和保持部分的区域，该应用也使得两个计划的粘合区域的粘合剂层与其间的粘合剂连续区域连续地连续地制成。之后，将窗玻璃和定位夹具放置在注射模具中，并将聚合物材料注入模具中。因此，覆盖部件和保持部形成为通过用于材料流动的连接部连接的形状，该连接部形成在粘接剂连续区域以外的位置。形成结果是，覆盖构件和保持部分粘合并固定到窗玻璃的后表面，其间具有粘合剂层。在上述成形过程之后，物料流的连接部分被去除。

5. 发明授权

US5589365A Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms 失效
标题翻译：通过培养某些微生物生产糖基化吲哚并吡咯咔唑衍生物的方法
公开(公告)号：US5589365A
公开(公告)日：1996-12-31
申请号：US381286
申请日：1995-01-31
申请人： Katsuhisa Kojiri , Hisao Kondo , Hiroharu Arakawa , Mitsuru Ohkubo , Hiroyuki Suda
发明人： Katsuhisa Kojiri , Hisao Kondo , Hiroharu Arakawa , Mitsuru Ohkubo , Hiroyuki Suda
IPC分类号： C07H19/044 , C12P19/28
CPC分类号： C12R1/01 , C07H19/044 , C12P19/28
摘要： A compound of formula (VIII) ##STR1## is added to a culture media containing Microtetraspora sp. A34549 or Saccharothrix aerocolonigenes ATCC 39243. The compound is glycosylated to form an indolopyrrolocarbazole of formula (VII) ##STR2##
摘要翻译：将式（VIII）化合物（VIII）加入到含有微型菌丝孢菌（Microtetraspora sp。）的培养基中。 A34549或产糖酵母（Saccharothrix aerocolonigenes）ATCC 39243。该化合物被糖基化以形成式（VII）的吲哚并吡咯并咔唑（VII）

6. 发明授权

US08501977B2 Platinum complex and pharmaceutical composition containing the same 失效
标题翻译：铂复合物和含有相同的药物组合物
公开(公告)号：US08501977B2
公开(公告)日：2013-08-06
申请号：US13060906
申请日：2009-08-25
申请人： Hisae Arai , Masaji Ohno , Hisao Kondo , Ikuko Arai
发明人： Hisae Arai , Masaji Ohno , Hisao Kondo , Ikuko Arai
IPC分类号： C07F15/00 , A61K31/28
CPC分类号： C07C55/07 , C07C61/04 , C07C211/38 , C07C2602/50 , C07F15/0093
摘要： A new platinum complex which has strong antitumor activity and has effect with smaller doses and a pharmaceutical composition containing the same are provided. A spiro[4,4]nonane-1,6-diamineplatinum(II) complex which is represented by a following general formula (A). (In the formula, X and Y are same or different, and X and Y represent halogen atoms respectively, or X and Y cooperatively represent a divalent residue which is described by a formula (Z).) The platinum complex has a strong antitumor activity and is efficacious as a therapeutic agent for malignant tumors.
摘要翻译：提供了具有强抗肿瘤活性并具有较小剂量效果的新型铂络合物和含有该铂络合物的药物组合物。由以下通式（A）表示的螺[4,4]壬烷-1,6-二氨基铂（II）络合物。（式中X和Y相同或不同，X和Y分别表示卤素原子，或X和Y表示二价残基，由式（Z）表示）。铂络合物具有强的抗肿瘤活性并且作为恶性肿瘤的治疗剂是有效的。

7. 发明授权

US08203669B2 Liquid crystal display device 有权
标题翻译：液晶显示装置
公开(公告)号：US08203669B2
公开(公告)日：2012-06-19
申请号：US12435003
申请日：2009-05-04
申请人： Hisao Kondo , Katsumi Tsuchida , Hisashi Narita , Shigenori Oota
发明人： Hisao Kondo , Katsumi Tsuchida , Hisashi Narita , Shigenori Oota
IPC分类号： G02F1/1335 , G02F1/1333
CPC分类号： G02F1/133615 , G02B6/0083 , G02B6/0085 , G02B6/009 , G02F2001/133628
摘要： A liquid crystal display device comprising a liquid crystal display panel, a backlight and a heat sink member is disclosed. The backlight comprises a light-guiding plate disposed on one principal surface side of the liquid crystal display panel, LED light sources disposed on an end surface of the light-guiding plate, a mounting board for mounting the LED light sources thereon and a thermally conductive member connected to the mounting board. The heat sink member is connected to the mounting board through the thermally conductive member.
摘要翻译：公开了一种包括液晶显示面板，背光和散热构件的液晶显示装置。背光源包括设置在液晶显示面板的一个主表面侧的导光板，设置在导光板的端面上的LED光源，用于在其上安装LED光源的安装板和导热板连接到安装板的构件。散热构件通过导热构件连接到安装板。

8. 发明授权

US06703373B1 Indolopyrrolocarbazole derivatives and antitumor agents 失效
标题翻译：吲哚吡咯咔唑衍生物和抗肿瘤剂
公开(公告)号：US06703373B1
公开(公告)日：2004-03-09
申请号：US10070825
申请日：2002-03-11
申请人： Katsuhisa Kojiri , Hisao Kondo , Hiroharu Arakawa , Mitsuru Ohkubo , Hiroyuki Suda
发明人： Katsuhisa Kojiri , Hisao Kondo , Hiroharu Arakawa , Mitsuru Ohkubo , Hiroyuki Suda
IPC分类号： A01N4304
CPC分类号： C07H19/00 , C07H15/00 , C07H19/22
摘要： A compound represented by the formula or a pharmaceutically acceptable salt thereof wherein R represents an unsubstituted pyridyl, furyl or thienyl group, or a pyridyl, furyl or thienyl group each of which has one or more substituents selected from the group consisting of a hydroxyl group, a lower alkoxy group, a hydroxy lower alkyl group and a hydroxy lower alkenyl group except that when the pyridyl, furyl or thienyl group has a lower alkoxy group as a substituent, each of which simultaneously has another substituent selected from the group consisting of a hydroxyl group, a lower alkoxy group, a hydroxy lower alkyl group and a hydroxy lower alkenyl group, m represents an integer of 1 to 3, and G represents a &bgr;-D-glucopyranosyl group, and the positions of substitution of the hydroxyl groups on the indolopyrrolocarbazole ring are the 1- and 11-positions, or the 2- and 10-positions, and an antitumore agent containing it as an effective ingredient. The compounds have a better antitumor action than known compounds having a similar structure.
摘要翻译：由下式表示的化合物或其药学上可接受的盐，其中R表示未取代的吡啶基，呋喃基或噻吩基，或吡啶基，呋喃基或噻吩基，其各自具有一个或多个选自羟基，低级烷氧基，羟基低级烷基和羟基低级烯基，不同之处在于当吡啶基，呋喃基或噻吩基具有低级烷氧基作为取代基时，其各自同时具有选自羟基的另一取代基，低级烷氧基，羟基低级烷基和羟基低级烯基，m表示1〜3的整数，G表示β-D-吡喃葡萄糖基，吲哚并吡咯并唑的羟基取代位置环是1-和11位，或2-和10-位，以及含有它作为有效成分的抗肿瘤剂。化合物具有更好的抗肿瘤比已知具有相似结构的化合物。

9. 发明授权

US06268512B1 Process for producing 3-methyl-2-oxoindoline 失效
标题翻译： 3-甲基-2-氧代二氢吲哚的制备方法
公开(公告)号：US06268512B1
公开(公告)日：2001-07-31
申请号：US09600019
申请日：2000-07-11
申请人： Hisao Kondo , Tetsuro Higashikawa
发明人： Hisao Kondo , Tetsuro Higashikawa
IPC分类号： C07D20712
CPC分类号： C07D209/34
摘要： The present invention is a process for producing 3-methyl-2-oxoindoline as defined by the following chemical formula (2), including heating of propionylphenylhydrazide as defined by the following chemical formula (1) in the presence of at least one kind of basic calcium compound, characterized in that an organic solvent withstanding at least at a temperature of 180° C. in the presence of the basic calcium compound is employed by at least an amount of equal weight to that of the propionylphenylhydrazide. With the construction mentioned above, even when the amount of calcium oxide is reduced down to as little as 15% of a conventionally used amount, at least 75% of a corresponding yield attained conventionally has been achieved. That is, not only control of the reaction and easy after treatment but also a high yield has been achieved;
摘要翻译：本发明是由以下化学式（2）定义的3-甲基-2-氧代二氢吲哚的制造方法，其中包括如下化学式（1）所定义的丙酰基苯基酰肼在至少一种碱性钙化合物，其特征在于，在碱性钙化合物的存在下，至少在180℃的温度下耐受的有机溶剂的使用量至少与丙酰基苯肼的重量相同。通过上述结构，即使氧化钙的量减少到常规使用量的少至15％，也达到了通常达到相应产率的至少75％。也就是说，不仅控制反应，而且处理容易，而且成品率高;

10. 发明授权

US5922860A Antitumor indolopyrrolocarbazole derivatives 失效
标题翻译：抗肿瘤吲哚并吡咯并咔唑衍生物
公开(公告)号：US5922860A
公开(公告)日：1999-07-13
申请号：US3602
申请日：1998-01-07
申请人： Katsuhisa Kojiri , Hisao Kondo , Hiroharu Arakawa , Mitsuru Ohkubo , Hiroyuki Suda
发明人： Katsuhisa Kojiri , Hisao Kondo , Hiroharu Arakawa , Mitsuru Ohkubo , Hiroyuki Suda
IPC分类号： C07C243/16 , C07D403/04 , C07D403/14 , C07D487/14 , C07H19/04 , C07H19/044 , C07H17/02 , C07H19/00 , C07H19/22
CPC分类号： C07D403/04 , C07C243/16 , C07D403/14 , C07D487/14 , C07H19/04 , C07H19/044
摘要： This invention relates to compounds of the general formula ##STR1## or pharmaceutically salts thereof, wherein R.sup.1 and R.sup.2 each represent an OH group, R.sup.1 is located at the 1- or 2-position, R.sup.2 is located at the 10- or 11-position, R.sup.2 is located at the 11-position when R.sup.1 is located at the 1-position, and R.sup.2 is located at the 10-position when R.sup.1 is located at the 2-position. The compounds of the present invention have an excellent antitumor effect and are hence useful as antitumor agents in the field of medicine.
摘要翻译：本发明涉及通式的化合物或其药学上可接受的盐，其中R 1和R 2各自表示OH基，R 1位于1或2位，R 2位于10或11位，R 2为当R1位于1位时位于11位，当R1位于2位时R2位于10位。本发明的化合物具有优异的抗肿瘤效果，因此可用作医药领域的抗肿瘤剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式